Fundraising Fox
Find your path to Colin
45 people in our graph can introduce you to Colin.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Caroline Haegeman to introduce you to Colin
You →Caroline · together at Athernal Bio (2024–2026) →Colin
Ask Jamie Chen to introduce you to Colin
You →Jamie · together at Swarm Oncology →Colin
Ask Sam Okafor to introduce you to Colin
You →Sam · 5 people · together at Doubletwist Inc. →Colin
Sign up to find every way you can get introduced to Colin
- Your email: the people you already email who know Colin
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Colin
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Colin Freund is chair and former founding CEO of Athernal Bio. With 18 years of experience in private and public biotechnology, he has led multinational teams across company leadership, strategic planning, business development, and M&A transactions exceeding $500 million, while managing regulatory strategy, commercial development, and fundraising activities in the US, Europe, and Asia.
Experience
- Athernal BioChair (former founding CEO)current2024 — presentCambridge
- mothers2mothersChair of the Boardcurrent2019 — present
- Swarm OncologyBoard Membercurrent2024 — presentLondon Area, United Kingdom
- Modra PharmaceuticalsBoard Membercurrent2024 — present
- Modra PharmaceuticalsCEO2017 — 2023Amsterdam Area, Netherlands
- TurbineBoard Member2024 — 2025
- Delin VenturesPartner2023 — 2025London, England, United Kingdom
- IMMvention Therapeutix, Inc.Board Member2024 — 2025
- Citryll B.V.Board Member2022 — 2024Oss, North Brabant, Netherlands
- QUE Oncology, Inc.Advisor2017
- QUE Oncology, Inc.Chief Executive Officer2015 — 2017Greater New York City Area | Atlanta, GA | Brisbane, Australia
- Transgene SAChief Business Officer 11/13-06/15, Senior Business Advisor (07/15-12/15)2013 — 2015Cambridge, MA | Strasbourg, France
- Agennix AGChief Business Officer2009 — 2013Princeton, NJ
- GPC Biotech AGSenior Vice President Business Development & Corporate Strategy2007 — 2009Princeton, NJ
- GPC Biotech AGVice-President, Business Development2003 — 2007Princeton, NJ
- GPC Biotech AGSenior Director, Business Development2002 — 2003Munich, Germany | Waltham, MA
- Doubletwist Inc.Vice President, Business Development1999 — 2001Oakland, CA
- the Boston Consulting GroupProject Leader1992 — 1999London, England | San Francisco, CA
Skills & more
+12 more
Strategic LeadershipPresentationsConsultingPartner Relationship ManagementContract NegotiationStakeholder EngagementExecutive LeadershipChange ManagementCommunicationStrategyLeadershipNegotiationLanguages English · French · German
From Colin's professional profile.
Frequently asked questions
- Who is Colin Freund?
- Colin Freund is chair and former founding CEO of Athernal Bio. With 18 years of experience in private and public biotechnology, he has led multinational teams across company leadership, strategic planning, business development, and M&A transactions exceeding $500 million, while managing regulatory strategy, commercial development, and fundraising activities in the US, Europe, and Asia.
- Where did Colin Freund go to school?
- Colin Freund studied at Stanford University Graduate School of Business (Masters, Business Administration); University of Cambridge (BA, Economics & Management Studies).
Same school
Also attended Stanford University Graduate School of Business2,000
+ 1,994 more
Also attended University of Cambridge1,682
+ 1,676 more
Shared employers
Also worked at Athernal Bio1
Also worked at Swarm Oncology5
Also worked at Modra Pharmaceuticals1
Also worked at Turbine10
+ 4 more